-
Full Article (HTML) (149) -
Full Article (PDF) (62) -
Send to Friends (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13908)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 7, 2015 (publication date) through Jul 4, 2022
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Usami M, Miyoshi M, Yamashita H. Gut microbiota and host metabolism in liver cirrhosis. World J Gastroenterol 2015; 21(41): 11597-11608 [PMID: 26556989 DOI: 10.3748/wjg.v21.i41.11597] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i41/11597.htm |
| Number | Citing Articles |
| 1 |
Antonella Borrelli, Patrizia Bonelli, Franca Maria Tuccillo, Ira D. Goldfine, Joseph L. Evans, Franco Maria Buonaguro, Aldo Mancini. Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches. Redox Biology 2018; 15: 467 doi: 10.1016/j.redox.2018.01.009
|
| 2 |
Cassandra Francella, Jane A. Foster. Burger's Medicinal Chemistry and Drug Discovery. 2021; : 1 doi: 10.1002/0471266949.bmc297
|
| 3 |
Jiachen Liu, Yantao Xu, Bimei Jiang. Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective. Frontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.586427
|
| 4 |
Yumeng Zhang, Min Zhao, Xue Jiang, Qiaoyu Qiao, Tingting Liu, Chunjie Zhao, Miao Wang. Comprehensive Analysis of Fecal Microbiome and Metabolomics in Hepatic Fibrosis Rats Reveal Hepatoprotective Effects of Yinchen Wuling Powder From the Host-Microbial Metabolic Axis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.713197
|
| 5 |
Man Chen, Junping Zheng, Xiaojuan Zou, Cheng Ye, Hui Xia, Ming Yang, Qinghua Gao, Qingxiong Yang, Hongtao Liu. Ligustrum robustum (Roxb.) blume extract modulates gut microbiota and prevents metabolic syndrome in high-fat diet-fed mice. Journal of Ethnopharmacology 2021; 268: 113695 doi: 10.1016/j.jep.2020.113695
|
| 6 |
Zidong Donna Fu, Julia Yue Cui. Remote Sensing Between Liver and Intestine: Importance of Microbial Metabolites. Current Pharmacology Reports 2017; 3(3): 101 doi: 10.1007/s40495-017-0087-0
|
| 7 |
Vanessa Stadlbauer, Irina Komarova, Ingeborg Klymiuk, Marija Durdevic, Alexander Reisinger, Andreas Blesl, Florian Rainer, Angela Horvath. Disease severity and proton pump inhibitor use impact strongest on faecal microbiome composition in liver cirrhosis. Liver International 2020; 40(4): 866 doi: 10.1111/liv.14382
|
| 8 |
Annette Bellar, Nicole Welch, Srinivasan Dasarathy. Exercise and physical activity in cirrhosis: opportunities or perils. Journal of Applied Physiology 2020; 128(6): 1547 doi: 10.1152/japplphysiol.00798.2019
|
| 9 |
Morten D. Jensen, Peter Jepsen, Hendrik Vilstrup, Lisbet Grønbæk. Increased Cancer Risk in Autoimmune Hepatitis: A Danish Nationwide Cohort Study. American Journal of Gastroenterology 2022; 117(1): 129 doi: 10.14309/ajg.0000000000001525
|
| 10 |
Michael Doulberis, Georgios Kotronis, Dimitra Gialamprinou, Jannis Kountouras, Panagiotis Katsinelos. Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota. Metabolism 2017; 71: 182 doi: 10.1016/j.metabol.2017.03.013
|
| 11 |
Akika Fukawa, Shunsuke Baba, Kaori Iwasawa, Makoto Yamaguchi, Akira Hosono. Dietary α-Lactalbumin protects against thioacetamide-induced liver cirrhosis by maintaining gut-liver axis function in rats. Bioscience, Biotechnology, and Biochemistry 2020; 84(1): 171 doi: 10.1080/09168451.2019.1660613
|
| 12 |
Alejandra Altamirano-Barrera, Misael Uribe, Norberto C. Chávez-Tapia, Natalia Nuño-Lámbarri. The role of the gut microbiota in the pathology and prevention of liver disease. The Journal of Nutritional Biochemistry 2018; 60: 1 doi: 10.1016/j.jnutbio.2018.03.006
|
| 13 |
Makoto Matsushita, Kazutoshi Fujita, Koji Hatano, Marco A. De Velasco, Hirotsugu Uemura, Norio Nonomura. Connecting the Dots Between the Gut–IGF-1–Prostate Axis: A Role of IGF-1 in Prostate Carcinogenesis. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.852382
|
| 14 |
Andrea Mancini, Francesca Campagna, Piero Amodio, Kieran M. Tuohy. Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy. Food & Function 2018; 9(3): 1373 doi: 10.1039/C7FO01528C
|
| 15 |
Chaoqun Li, Beili Zhang, Xin Wang, Xionge Pi, Xuan Wang, Huihui Zhou, Kangsen Mai, Gen He. Improved utilization of soybean meal through fermentation with commensal Shewanella sp. MR-7 in turbot (Scophthalmus maximus L.). Microbial Cell Factories 2019; 18(1) doi: 10.1186/s12934-019-1265-z
|
| 16 |
Michael X. Chen, San-Yuan Wang, Ching-Hua Kuo, I-Lin Tsai. Metabolome analysis for investigating host-gut microbiota interactions. Journal of the Formosan Medical Association 2019; 118: S10 doi: 10.1016/j.jfma.2018.09.007
|
| 17 |
Saba Sadeghirashed, Fatemeh Kazemi, Saba Taheri, Maryam Tajabadi Ebrahimi, Javad Arasteh. A novel probiotic strain exerts therapeutic effects on mouse model of multiple sclerosis by altering the expression of inflammasome and IDO genes and modulation of T helper cytokine profile. Metabolic Brain Disease 2022; 37(1): 197 doi: 10.1007/s11011-021-00857-7
|
| 18 |
Natalia Nuño-Lámbarri, Norberto C. Chávez-Tapia, Misael Uribe. Encyclopedia of Food Chemistry. 2019; : 387 doi: 10.1016/B978-0-08-100596-5.21759-9
|
| 19 |
Patricia P. Bloom, Jesús M. Luévano, Kelsey J. Miller, Raymond T. Chung. Deep stool microbiome analysis in cirrhosis reveals an association between short-chain fatty acids and hepatic encephalopathy. Annals of Hepatology 2021; 25: 100333 doi: 10.1016/j.aohep.2021.100333
|
| 20 |
Mengmeng Shao, Yi Zhu. Long-term metal exposure changes gut microbiota of residents surrounding a mining and smelting area. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-61143-7
|
| 21 |
Yajing Shi, Yufang Leng, Disheng Liu, Xin Liu, Yixing Ren, Jianmin Zhang, Feng Chen. Research Advances in Protective Effects of Ursolic Acid and Oleanolic Acid Against Gastrointestinal Diseases. The American Journal of Chinese Medicine 2021; 49(02): 413 doi: 10.1142/S0192415X21500191
|
| 22 |
Cyriac Abby Philips, Philip Augustine, Praveen Kumar Yerol, Ganesh Narayan Ramesh, Rizwan Ahamed, Sasidharan Rajesh, Tom George, Sandeep Kumbar. Modulating the Intestinal Microbiota: Therapeutic Opportunities in Liver Disease. Journal of Clinical and Translational Hepatology 2019; (X): 1 doi: 10.14218/JCTH.2019.00035
|
| 23 |
Xiu Sun, Calvin Q. Pan, Huichun Xing. Effect of microbiota metabolites on the progression of chronic hepatitis B virus infection. Hepatology International 2021; 15(5): 1053 doi: 10.1007/s12072-021-10230-6
|
| 24 |
Yasushi Okura, Tadashi Namisaki, Shinya Sato, Kei Moriya, Takemi Akahane, Mitsuteru Kitade, Hideto Kawaratani, Kosuke Kaji, Hiroaki Takaya, Yasuhiko Sawada, Naotaka Shimozato, Kenichiro Seki, Soichiro Saikawa, Keisuke Nakanishi, Masanori Furukawa, Yukihisa Fujinaga, Takuya Kubo, Daisuke Kaya, Yuki Tsuji, Takahiro Ozutsumi, Koh Kitagawa, Tsuyoshi Mashitani, Hiroyuki Ogawa, Koji Ishida, Akira Mitoro, Junichi Yamao, Hitoshi Yoshiji. Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosis. Hepatology Research 2019; 49(2): 232 doi: 10.1111/hepr.13249
|
| 25 |
Yi Shao, Yuancong Jiang, Hui Li, Feng Zhang, Zhenhua Hu, Shusen Zheng. Characteristics of mouse intestinal microbiota during acute liver injury and repair following 50% partial hepatectomy. Experimental and Therapeutic Medicine 2021; 22(3) doi: 10.3892/etm.2021.10385
|
| 26 |
Hua Zha, Yanfei Chen, Jieyun Wu, Kevin Chang, Yanmeng Lu, Hua Zhang, Jiaojiao Xie, Qiangqiang Wang, Ruiqi Tang, Lanjuan Li. Characteristics of three microbial colonization states in the duodenum of the cirrhotic patients. Future Microbiology 2020; 15(10): 855 doi: 10.2217/fmb-2019-0270
|
| 27 |
Ruipeng Zheng, Guoqiang Wang, Zhiqiang Pang, Nan Ran, Yinuo Gu, Xuewa Guan, Yuze Yuan, Xu Zuo, He Pan, Jingtong Zheng, Fang Wang. Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma. Cancer Medicine 2020; 9(12): 4232 doi: 10.1002/cam4.3045
|
| 28 |
Maria Adriana Neag, Andrei Otto Mitre, Adrian Catinean, Anca Dana Buzoianu. Overview of the microbiota in the gut-liver axis in viral B and C hepatitis. World Journal of Gastroenterology 2021; 27(43): 7446-7461 doi: 10.3748/wjg.v27.i43.7446
|
| 29 |
Haifeng Lu, Liang Chen, Xiaxia Pan, Yujun Yao, Hua Zhang, Xiaofei Zhu, Xiaobin Lou, Chunxia Zhu, Jun Wang, Lanjuan Li, Zhongwen Wu. Lactitol Supplementation Modulates Intestinal Microbiome in Liver Cirrhotic Patients. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.762930
|
| 30 |
Haruka Sagi, Shuichi Shibuya, Tamotsu Kato, Yumiko Nakanishi, Arisa Tsuboi, Shigeharu Moriya, Hiroshi Ohno, Hirokuni Miyamoto, Hiroaki Kodama, Takahiko Shimizu. SOD1 deficiency alters gastrointestinal microbiota and metabolites in mice. Experimental Gerontology 2020; 130: 110795 doi: 10.1016/j.exger.2019.110795
|
| 31 |
Wenwen Zhao, Meng Xiao, Jie Yang, Li Zhang, Yinying Ba, Rongrong Xu, Zongyang Liu, Haiyan Zou, Ping Yu, Xia Wu, Xiaoqing Chen. The combination of Ilexhainanoside D and ilexsaponin A1 reduces liver inflammation and improves intestinal barrier function in mice with high-fat diet-induced non-alcoholic fatty liver disease. Phytomedicine 2019; 63: 153039 doi: 10.1016/j.phymed.2019.153039
|
| 32 |
Miwa Katagiri, Makoto Kuroda, Tsuyoshi Sekizuka, Norihide Nakada, Yukitaka Ito, Masanobu Otsuka, Manabu Watanabe, Shinya Kusachi. Comprehensive Genomic Survey of Antimicrobial-Resistance Bacteria in the Sewage Tank Replacement with Hospital Relocation. Infection and Drug Resistance 2021; : 5563 doi: 10.2147/IDR.S336418
|
| 33 |
Suraphan Panyod, Wei-Kai Wu, Chieh-Chang Chen, Ming-Shiang Wu, Chi-Tang Ho, Lee-Yan Sheen. Modulation of gut microbiota by foods and herbs to prevent cardiovascular diseases. Journal of Traditional and Complementary Medicine 2021; doi: 10.1016/j.jtcme.2021.09.006
|
| 34 |
M. D. Akhmedova, G. Yu. Sultonova, A. M.-T. Bektimirov, A. N. Barinova. The state of intestinal microflora in patients with cirrhosis of the liver of viral etiology and the correction of its treatment. HIV Infection and Immunosuppressive Disorders 2021; 13(1): 97 doi: 10.22328/2077-9828-2021-13-1-97-105
|
| 35 |
Zeinab Ashour, Rasha Shahin, Zeinab Ali-Eldin, Mohamed El-Shayeb, Tarek El-Tayeb, Salwa Bakr. Potential impact of gut Lactobacillus acidophilus and Bifidobacterium bifidum on hepatic histopathological changes in non-cirrhotic hepatitis C virus patients with different viral load. Gut Pathogens 2022; 14(1) doi: 10.1186/s13099-022-00501-4
|
| 36 |
Ankita Chatterjee, Priyadarshi Basu. Nutrition and Functional Foods in Boosting Digestion, Metabolism and Immune Health. 2022; : 99 doi: 10.1016/B978-0-12-821232-5.00023-9
|
| 37 |
Sergio Salgüero, David Rojo, Juan Berenguer, Juan González‐García, Amanda Fernández‐Rodríguez, Oscar Brochado‐Kith, Cristina Díez, Victor Hontañon, Ana Virseda‐Berdices, Javier Martínez, Luis Ibañez‐Samaniego, Elba Llop‐Herrera, Coral Barbas, Salvador Resino, María A. Jiménez‐Sousa, Luis Ibáñez‐Samaniego, Leire Pérez‐Latorre, Diego Rincón, Teresa Aldámiz‐Echevarría, Vega Catalina, Pilar Miralles, Francisco Tejerina, María C Gómez‐Rico, Esther Alonso, José M Bellón, Rafael Bañares, José Arribas, José I Bernardino, Carmen Busca, Javier García‐Samaniego, Víctor Hontañón, Luz Martín‐Carbonero, Rafael Micán, María L Montes‐Ramírez, Victoria Moreno, Antonio Olveira, Ignacio Pérez‐Valero, Eulalia valencia, Juan González‐García, Elba Llop, José Luis Calleja, Agustín Albillos, Marta de Miguel, María Yllescas, Herminia Esteban. Plasma metabolomic fingerprint of advanced cirrhosis stages among HIV/HCV‐coinfected and HCV‐monoinfected patients. Liver International 2020; 40(9): 2215 doi: 10.1111/liv.14580
|
| 38 |
Anne Maiden, Shannon Scott, Erin Raney, Marisa Strobridge. Nonalcoholic Steatohepatitis: Case-Based Focused on Pediatric and Adult Guidelines. Osteopathic Family Physician 2021; : 29 doi: 10.33181/13024
|
| 39 |
Maria Adriana Neag, Adrian Catinean, Dana Maria Muntean, Maria Raluca Pop, Corina Ioana Bocsan, Emil Claudiu Botan, Anca Dana Buzoianu. Probiotic Bacillus Spores Protect Against Acetaminophen Induced Acute Liver Injury in Rats. Nutrients 2020; 12(3): 632 doi: 10.3390/nu12030632
|
| 40 |
Hao Zhang, Ani Yan, Xiaoyun Liu, Yi Ma, Fangfang Zhao, Mengzhi Wang, Jaun J. Loor, Hongrong Wang. Melatonin ameliorates ochratoxin A induced liver inflammation, oxidative stress and mitophagy in mice involving in intestinal microbiota and restoring the intestinal barrier function. Journal of Hazardous Materials 2021; 407: 124489 doi: 10.1016/j.jhazmat.2020.124489
|
| 41 |
Effect of dark environment on intestinal flora and expression of genes related to liver metabolism in zebrafish (Danio rerio). Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 2021; 249: 109100 doi: 10.1016/j.cbpc.2021.109100
|
| 42 |
Shouquan Wu, Minggui Wang, Miaomiao Zhang, Jian-Qing He. Metabolomics and microbiomes for discovering biomarkers of antituberculosis drugs-induced hepatotoxicity. Archives of Biochemistry and Biophysics 2022; 716: 109118 doi: 10.1016/j.abb.2022.109118
|
| 43 |
Daniela Campion, Ilaria Giovo, Paola Ponzo, Giorgio M Saracco, Federico Balzola, Carlo Alessandria. Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis. World Journal of Hepatology 2019; 11(6): 489-512 doi: 10.4254/wjh.v11.i6.489
|
| 44 |
Thomas Malikowski, Sahil Khanna, Darrell S. Pardi. Fecal microbiota transplantation for gastrointestinal disorders. Current Opinion in Gastroenterology 2017; 33(1): 8 doi: 10.1097/MOG.0000000000000326
|
| 45 |
A Roda, R Aldini, C Camborata, S Spinozzi, P Franco, M Cont, A D'Errico, F Vasuri, A Degiovanni, L Maroni, L Adorini. Metabolic Profile of Obeticholic Acid and Endogenous Bile Acids in Rats with Decompensated Liver Cirrhosis. Clinical and Translational Science 2017; 10(4): 292 doi: 10.1111/cts.12468
|
| 46 |
Susanne Feder, Reiner Wiest, Thomas S. Weiss, Charalampos Aslanidis, Doris Schacherer, Sabrina Krautbauer, Gerhard Liebisch, Christa Buechler. Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels are not associated with severity of liver disease and are inversely related to cholesterol in a cohort of thirty eight patients with liver cirrhosis. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01431-x
|
| 47 |
Takashi Himoto, Tsutomu Masaki. Current Trends of Essential Trace Elements in Patients with Chronic Liver Diseases. Nutrients 2020; 12(7): 2084 doi: 10.3390/nu12072084
|
| 48 |
Bingxian Liu, Qiwen Zeng, Hanming Chen, Jianzhao Liao, Yuman Bai, Qingyue Han, Na Qiao, Shuzhou Wang, Khalid Mehmood, Riaz Hussain, Bhutto Zohaib Ahmed, Zhaoxin Tang, Hui Zhang, Ying Li. The hepatotoxicity of altrazine exposure in mice involves the intestinal microbiota. Chemosphere 2021; 272: 129572 doi: 10.1016/j.chemosphere.2021.129572
|
| 49 |
Yuchen Wang, Bashar M. Attar, Rohit Agrawal, Ishaan Vohra, Muhammad Zain Farooq, Sheeba Ba Aqeel, Melchor Demetria. Non-hepatic Cancers Independently Predict Liver Decompensation Events. Journal of Gastrointestinal Cancer 2021; 52(2): 523 doi: 10.1007/s12029-020-00409-9
|
| 50 |
Themistoklis Kourkoumpetis, Gagan Sood. Pathogenesis of Alcoholic Liver Disease. Clinics in Liver Disease 2019; 23(1): 71 doi: 10.1016/j.cld.2018.09.006
|
| 51 |
Marta Ramirez, Nuria Pell, Marc Mejias, Mercedes Fernandez. Pericyte Biology in Different Organs. Advances in Experimental Medicine and Biology 2019; 1122: 73 doi: 10.1007/978-3-030-11093-2_5
|
| 52 |
Juan Dai, Xiao Yang, Ya Yuan, Youzhen Jia, Guibing Liu, Nan Lin, Hang Xiao, Lishi Zhang, Jinyao Chen. Toxicity, gut microbiota and metabolome effects after copper exposure during early life in SD rats. Toxicology 2020; : 152395 doi: 10.1016/j.tox.2020.152395
|
| 53 |
Stephen D. H. Malnick, David Fisher, Marina Somin, Manuela G. Neuman. Treating the Metabolic Syndrome by Fecal Transplantation—Current Status. Biology 2021; 10(5): 447 doi: 10.3390/biology10050447
|
| 54 |
David Porras, Esther Nistal, Susana Martínez-Flórez, Sandra Pisonero-Vaquero, José Luis Olcoz, Ramiro Jover, Javier González-Gallego, María Victoria García-Mediavilla, Sonia Sánchez-Campos. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. Free Radical Biology and Medicine 2017; 102: 188 doi: 10.1016/j.freeradbiomed.2016.11.037
|
| 55 |
Sarha A. L. Queiroz, Alyne M. M. Ton, Thiago M. C. Pereira, Bianca P. Campagnaro, Larissa Martinelli, Aitor Picos, Manuel Campos-Toimil, Elisardo C. Vasquez. The Gut Microbiota-Brain Axis: A New Frontier on Neuropsychiatric Disorders. Frontiers in Psychiatry 2022; 13 doi: 10.3389/fpsyt.2022.872594
|
| 56 |
Xiao Wei, Shan Jiang, Yuye Chen, Xiangna Zhao, Huan Li, Weishi Lin, Boxing Li, Xuesong Wang, Jing Yuan, Yansong Sun. Cirrhosis related functionality characteristic of the fecal microbiota as revealed by a metaproteomic approach. BMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0534-0
|
| 57 |
Andrei Voiosu, Signe Wiese, Theodor Voiosu, Flemming Bendtsen, Søren Møller. Bile acids and cardiovascular function in cirrhosis. Liver International 2017; 37(10): 1420 doi: 10.1111/liv.13394
|
| 58 |
Shukai Zhan, Na Li, Caiguang Liu, Ren Mao, Dongxuan Wu, Tong Li, Minhu Chen, Xiaojun Zhuang, Zhirong Zeng. Intestinal Fibrosis and Gut Microbiota: Clues From Other Organs. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.694967
|
| 59 |
Hiroshi Fukui. Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?. Diseases 2019; 7(4): 58 doi: 10.3390/diseases7040058
|
| 60 |
Xiaoli Zhang, Yunpeng Dong, Guoying Sun, Ahmed A. Hasan, Mei Tian, Suimin Zeng, Jing Li, Shiyu Zeng, Jun Ma, Jian Li, Berthold Hocher. Paternal Programming of Liver Function and Lipid Profile Induced by a Paternal Pre-Conceptional Unhealthy Diet: Potential Association with Altered Gut Microbiome Composition. Kidney and Blood Pressure Research 2019; 44(1): 133 doi: 10.1159/000497487
|
| 61 |
Yaowen Chen, Pu Liu, Runyan Liu, Shuofeng Hu, Zhen He, Guohua Dong, Chao Feng, Sijing An, Xiaomin Ying, Jian Xu. Comprehensive Strain-Level Analysis of the Gut Microbe Faecalibacterium prausnitzii in Patients with Liver Cirrhosis. mSystems 2021; 6(4) doi: 10.1128/mSystems.00775-21
|
| 62 |
Junli Ma, Qihang Zhou, Houkai Li. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy. Nutrients 2017; 9(10): 1124 doi: 10.3390/nu9101124
|
| 63 |
Dana Tedesco, Manoj Thapa, Chui Yoke Chin, Yong Ge, Minghao Gong, Jing Li, Sanjeev Gumber, Patrick Speck, Elizabeth J. Elrod, Eileen M. Burd, William H. Kitchens, Joseph F. Magliocca, Andrew B. Adams, David S. Weiss, Mansour Mohamadzadeh, Arash Grakoui. Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor–Positive Cells and Pathogenesis of Cholestatic Liver Disease. Gastroenterology 2018; 154(8): 2178 doi: 10.1053/j.gastro.2018.02.019
|
| 64 |
Gut–organ axis: a microbial outreach and networking. Letters in Applied Microbiology 2021; 72(6): 636 doi: 10.1111/lam.13333
|
| 65 |
Xia Liu, Runzhou Sun, Zhaozhen Li, Ruixin Xiao, Pengfei Lv, Xiangrong Sun, Mark A. Olson, Yanling Gong. Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis. Archives of Biochemistry and Biophysics 2021; 711: 109019 doi: 10.1016/j.abb.2021.109019
|